Drawing for KITVI (BEZUCLASTINIB) TABLETS

USPTO serial 50064173

KITVI (BEZUCLASTINIB) TABLETS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
WUDARSKY, MINDY CHEK
Law office
TMO LAW OFFICE 117

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with KITVI (BEZUCLASTINIB) TABLETS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gabriel M Gillmeyer

Gabriel M Gillmeyer Ropes & Gray LLPPrudential Tower, 800 Boylston StreetBoston, MA 02199-3600United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2026DOCKASSIGNED TO EXAMINER—
Nov 16, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 16, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 21, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 21, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance